A biotechnology company may have a focused market, a complex solution, and only a limited number of organizations that fit its commercial priorities. That can make account-based marketing appealing, but naming target accounts is only the beginning. The strategy becomes useful when the team can explain why each account belongs on the list and how it plans to engage the people involved.
Make the Account List Defensible
Start with criteria tied to the business, such as scientific or operational fit, relevant capabilities, geography, and the problem the offering addresses. Then record the evidence behind each selection. A transparent rationale helps marketing and sales challenge assumptions before they become campaign decisions.
In biotechnology, one organization can include distinct stakeholders with different questions: a scientific leader may focus on evidence, while an operations or procurement contact may need to understand implementation. Map roles and likely information needs rather than treating the account as a single person. The map should reflect what the team knows and mark gaps clearly.
Match Content to the Decision
Use account research to choose a relevant next conversation, not to personalize every sentence with a company name. A technical explainer, a case-based discussion, or a webinar with a subject-matter expert can each help address a different question. The format should follow the audience’s needs and the decision they are working through.
Coordinate outreach across marketing and sales so that an account does not receive disconnected messages from separate teams. Agree on the campaign purpose, useful engagement signals, and a reasonable follow-up action. If a contact downloads a technical guide, for example, the next step should offer relevant context rather than repeat the same offer.
Learn Before Expanding
Review account progress for patterns in reach, engagement, and conversations—not just a single campaign response. Which roles are participating? Which questions recur? Where does interest stop moving forward? These observations can expose a content gap or a mistaken assumption about the buying group.
For a focused biotechnology market, a smaller account list with a clear rationale is more actionable than a broad list built on vague fit. Define the criteria, map the people and their questions, then select content that supports a real decision. Expand only when the team can explain what it learned.